Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Eagle’s Eye View: SUMMIT: A Look Into BMI, Adiposity, Tirzepitide and HFpFF
  In this week’s View, Dr. Eagle looks at the SUMMIT trial and considers how body mass index (BMI) and central adiposity affect tirzepatide outcomes for heart failure with preserved ejection fraction (HFpEF).
• SOGALDI-PEF: Dapagliflozin Plus Spironolactone More Effective Than Monotherapy
  In patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), the combination of dapagliflozin plus spironolactone led to a greater reduction in NT-proBNP levels than dapagliflozin alone, indicating improved cardiac stress...
• What is the Relationship Between Age, Weight Gain and Neuroinflammation in Youths?
  Values of restricted normalized isotropic (RNI) scaling factor, a brain microstructural marker that may suggest neuroinflammation, were associated with age and BMI among youths with varying weight gain, with a robust association with greater increases in BMI in young girls...
• How Many Steps a Day to Reduce CVD and CV Death?
  New research shows that just 7,000 steps a day is associated with clinically meaningful improvements in health outcomes, including reductions in cardiovascular disease incidence and death – and offering a more realistic target than the previously touted 10,000 steps a day.
• Physical Activity Declines Over Time, Persists After CVD Diagnosis
  Adults experience steep declines in moderate to vigorous-intensity physical activity (MVPA) before developing cardiovascular disease, with exercise reduction persisting after diagnosis, according to a cohort and nested case-control study published July 23 in JAMA Cardiology.